Ranked board
GLP-1 providers that say they treat women, and what a year at each really costs
This board is built from one fact per company, read off that company's own site and quoted with the date on its review: who it says it serves. A seller is here because it addresses women specifically, or because it publishes parallel programmes for both sexes. A seller that says nothing on the point is not here — not because it refuses women, but because nobody has established that it serves them, and a page headed like this one should not be making that assumption on twenty companies at once. What this board is not is a claim about bodies: it ranks pricing pages, and nothing on this site asserts a clinical difference between the sexes.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
What gets on this board
Every company with a published review here that sells a GLP-1 and whose own published words say it serves women — either by addressing women specifically, or by publishing programmes for both sexes. Each appears once, on its cheapest GLP-1 over a year. A company whose own site says nothing about who it treats is on NEITHER this board nor the men's one: an absent record means the question has not been settled first-party, and it is not read as a yes. Companies we did establish an audience for and still left off are named below with the sentences that decided it.
What decides the order
Ranked by true-year cost, cheapest first — the price of one cycle with no commitment, multiplied by the number of times a year it is actually billed. Nothing is pinned, sponsored, or lifted into position.
What the spread looks like
$1,188
Cheapest year
$5,976
Dearest year
$4,788
Between the two
Ranked by what a year actually costs
The advertised column is what the company leads with. The walk-away column is what one cycle costs if you stop after it. The year column is the second of those multiplied by the number of times a year it is genuinely billed — which is thirteen, not twelve, for anyone on a four-week cycle.
| Company & compound | Advertised | Walk-away | True year | Visit |
|---|---|---|---|---|
| $99 | $99 | $1,188$99 × 12 | Visit | |
| $133 | $150+$17 on the ad | $1,800$150 × 12 | Visit | |
| $138 | $178+$40 on the ad | $2,136$178 × 12 | Visit | |
| $119 | $179+$60 on the ad | $2,148$179 × 12 | Visit | |
| $99 | $198+$99 on the ad | $2,376$198 × 12 | Visit | |
| $159 | $199+$40 on the ad | $2,388$199 × 12 | Visit | |
| $249 | $249 | $2,988$249 × 12 | Visit | |
| $149 | $264.50+$115.50 on the ad | $3,174$264.50 × 12 | Visit | |
| $217 | $297+$80 on the ad | $3,564$297 × 12 | Visit | |
| $188 | $298+$110 on the ad | $3,576$298 × 12 | Visit | |
| $179 | $299+$120 on the ad | $3,588$299 × 12 | Visit | |
| $160 | $315+$155 on the ad | $3,780$315 × 12 | Visit | |
| $238 | $498+$260 on the ad | $5,976$498 × 12 | Visit |
Every price was read off the company's own page on the date shown beside it. The capture procedure, and the five ways a price gets captured wrong, are on our methodology page.
What this board leaves off, and why
3 priced rows in our reviews look like they could belong on this board and are deliberately not on it. Each is named here with the reason, because a ranking you cannot see the edges of is one you have to take on trust — and every one of these prices is published in full on the review it came from.
MangoRx — Semaglutide — compounded oral tablet
MangoRx sells to men and titles the page so. The weight-loss page this row is priced from carries the title "Medical Weight Loss for Men | MangoRx" and is headed "Crafted Solutions for Men Like You", and its FAQ answers the question "Does MangoRx offer treatments for women?" with "Many treatment options are specifically selected for individuals whose biological sex is male" — without saying which ones. That is the company's own account of who its products are for, read on 2026-08-09, so this row is on the men's board instead.
PeterMD — Semaglutide + B12 — compounded
PeterMD's own homepage leads with "Modern men's healthcare" and its meta description states "Our mission is to make men's health as accessible as possible", read first-party on 2026-08-09. It publishes no statement refusing women — this is positioning rather than an eligibility rule — but its nav's one apparent women's link redirects to the homepage, and its 110-page sitemap carries three men's programme pages and no women's counterpart. Ranking it here would credit it with something it does not claim.
PeterMD — Tirzepatide — compounded
The same company and the same reason. PeterMD's tirzepatide price is on its review in full, and this row is ranked on the men's board.
Key terms
Show definitions
- Walk-away price
- What one cycle costs at the standing, no-commitment rate — what you pay if you stop after it. Not a prepay tier and not a first-month promotion.
- True year
- The walk-away price multiplied by the number of times it is actually billed in a year: 12 on a calendar-month cycle, 13 on a four-week cycle.
- Advertised price
- The figure the company leads with on its own pricing page. It is shown here beside the price you pay rather than instead of it.
What this board does not tell you
Whether you qualify
Coverage varies by state, and several of these companies serve fewer states than they appear to. Each review names the exclusions its company actually discloses.
Whether the care is good
This is a cost ranking and nothing else. We have not assessed anyone's clinical care, and there is no quality score anywhere on this site.
What your insurer pays
Every figure here is a cash price. What a covered drug costs you depends on your own plan's formulary and deductible, and no public source publishes a per-drug copay.
Whether the price will hold
Plans restructure without notice. Every row carries the date it was read so you can see how old the number is before you rely on it.
Frequently asked questions
Does this board make any claim about how GLP-1s affect women?
No, and it never will. Nothing on this site makes a claim about how any medicine behaves in one sex versus another — that is a clinical question, it is not answerable from a pricing page, and it is not what we have researched. The only fact this board reads about a company is who that company says it serves, quoted from its own site. Everything else on the page is a price.
Why are there fewer companies here than on the main GLP-1 board?
Because most of the sellers we have priced publish nothing at all about who they treat, and we would rather show you a shorter board than pad it. Their eligibility copy is about BMI, medical history and which state you live in, and it names neither sex — which tells you nothing either way. Rather than read that silence as a yes and list them here, we leave them off both this board and the men's one, and the main GLP-1 board prices every one of them.
How was each company on this board established?
By reading its own site and quoting it, never by looking at the brand name — a rule that matters more than it sounds. One company in this registry has no gendered name at all and publishes matched men's and women's weight-loss pages with the same four products at the same four prices. Another trades under a name that reads as women-only and was, for a while, wrongly recorded as unverifiable because automated fetches of its site were being blocked. Each review states which pages were read and on what date.
Does a company on this board specialise in treating women?
Mostly not, and the board does not claim it. Most of these sellers publish programmes for both sexes, which is what qualifies them; one addresses women specifically. That distinction is on each company's review rather than encoded in the ranking, because the order here is decided by cost and nothing else.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.